Abstract
Immunoglobulin-like transcripts (ILTs) encode several Ig-SF receptors which are structurally and functionally related to killer cell inhibitory receptors (KIRs) and are expressed on lymphoid and/or on myeloid cells (Yokoyama 1997 Table 1). ILTs are characterized by two or four homologous extracellular Ig-SF domains and can be classified by differing transmembrane and cytoplasmic domains (Samaridis and Colonna 1997). One subset of ILT receptors displays long cytoplasmic tails containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs). These receptors mediate inhibition of cell activation by recruiting protein tyrosine phos-phatase SHP-1 (Cella et al. 1997a; Cosman et al. 1997; Colonna et al. 1997; Arm et al. 1997; Colonna et al. 1998). Another subset of ILT receptors contains short cytoplasmic domains that lack kinase homology or recognizable motifs for signaling mediators. In addition, they are characterized by the presence of a single basic arginine residue within the hydrophobic transmembrane domain (Colonna et al. 1997; Borges et al. 1997). These ILT receptors closely resemble activating natural killer (NK) cell receptors, which share a positively charged lysine residue in the transmembrane domain and a short cytoplasmic domain that lacks sequence motifs implicated in signal transduction (Biassoni et al. 1996). To transduce signals, activating NK cell receptors associate with an immunoreceptor tyrosine-based activation motif (ITAM)-containing subunit called DAP 12 (Olcese et al. 1997; Lanier et al. 1998a, b; Smith et al. 1998; Campbell et al. 1998). Because of these structural similarities, it seems most likely that ILT receptors with short cytoplasmic tails also activate cells and use an associated protein to transduce stimulatory signals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Arm JP, Nwankwo C, Austen KF (1997) Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49Bl inhibitory receptor. J Immunol 159:2342–2349
Bahram S, Bresnahan M, Geraghty DE, Spies T (1994) A second lineage of mammalian major histo-compatibility complex class I genes. Proc Natl Acad Sci USA 91:6259–6263
Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L (1996) The human leukocyte antigen (HLA)-C-specific “activatory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 183:645–650
Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet J-P, Abraham RT, Leibson, PJ (1996) Sequential Involvement of Lck and SHP-1 with MHC-Recognizing Receptors on NK Cells Inhibits FcR-Initiated Tyrosine Kinase Activation. Immunity 5:629–638
Borges L, Hsu ML, Fanger N, Kubin M, Cosman D (1997) A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159:5192–5196
Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187:813–818
Braud V, Jones EY, McMichael A (1997) The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 27:1164–1169
Braud VM, Allan DS, O’Callaghan CA, Soderstrom K, D’Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2 A, B, and C. Nature 391:795–799
Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO (1996) Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4:77–85
Burshtyn DN, Yang W, Yi T, Long EO (1997) A novel phosphotyrosine motif with a critical amino acid at position-2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. J Biol Chem 16, 272:13066–13072
Campbell KS, Dessing M, Lopez Botet M, Cella M, Colonna M (1996) Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1 C. J Exp Med 184:93–100
Campbell KS, Cella M, Carretero M, Lopez-Botet M, Colonna M (1998) Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur J Immunol 28:599–609
Carretero M, Palmieri G, Llano M, Tullio V, Santoni A, Geraghty DE, Lopez-Botet M (1998) Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur J Immunol 28:280–291
Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M (1997a) A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185:1743–1751
Cella M, Sallusto F, Lanzavecchia A (1997b) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10–16
Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809–1818
Colonna M, Samaridis J, Cella M, Angman L, Allen R, O’Callaghan C, Dunbar R, Ogg G, Cerundolo V, Rolink A (1998) Human myelomonocytic cells express an inhibitory receptor for classical and non-classical MHC class I molecules. J Immunol 160:3096–3100
Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273–282
Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH (1995) The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RUB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3:635–646
Fry AM, Lanier LL, Weiss A (1996) Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1 C. J Exp Med 184:295–300
Hayami K, Fukuta D, Nishikawa Y, Yamashita Y, Inui M, Ohyama Y, Hikida M, Ohmori H, Takai T (1997) Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J Biol Chem 272:7320–7327
Hashimoto K, Hirai M, Kurosawa Y (1995) A gene outside the human MHC related to classical HLA class I genes. Science 269:693–695
Kubagawa H, Burrows PD, Cooper MD (1997) A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA 94:5261–5266
Lanier LL, Corliss B, Wu J, Leong C, Phillips JH (1998a) Immunoreceptor DAP 12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703–707
Lanier LL, Corliss B, Wu J, Phillips JH (1998b) Association of DAP12 with activating CD94/NKG2 C NK cell receptors. Immunity 8:693–701
Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty, DE (1998a) HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 160:4951–4960
Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE (1998b) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2 A. Proc Natl Acad Sci USA 95:5199–5204
Leong CC, Chapman TL, Bjorkman PJ, Formankova D, Mocarski ES, Phillips JH, Lanier LL (1998) Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 187:1681–1687
Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier JC, Vivier E (1996) Human and mouse killer-cell inhibitory receptors recruit PTP1 C and PTP1D protein tyrosine phosphatases. J Immunol 156:4531–4534
Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier EJ (1997) Human killer cell act-ivatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 158:5083–5086
Ono M, Bolland S, Tempst P, Ravetch JV (1996) Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 383:263–266
Philip R, Epstein LB (1986) Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon, and interleukin-1. Nature 323:86–89
Porcelli SA (1995) The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol 59:1–98
Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL (1997) The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514–517
Samaridis J, Colonna M (1997) Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 27:660–665
Smith KM, Wu J, Bakker AB, Phillips JH, Lanier LL (1998) Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol 161:7–10
Torkar M, Norgate Z, Colonna M, Trowsdale J, Wilson MJ (1998) Isotypic variation in arrangement of Immunoglobulin-like transcripts/killer cell inhibitory receptor loci in the leukocyte receptor complex. Eur J Immunol 28:3959–3967
Wagtmann N, Rojo S, Eichler E, Mohrenweiser H, Long EO (1997) A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol 7:615–618
Yokoyama WM (1997) What goes up must come down: the emerging spectrum of inhibitory receptors. J Exp Med 186:1803–1808
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Colonna, M., Navarro, F., López-Botet, M. (1999). A Novel Family of Inhibitory Receptors for HLA Class I Molecules That Modulate Function of Lymphoid and Myeloid Cells. In: Daëron, M., Vivier, E. (eds) Immunoreceptor Tyrosine-based Inhibition Motifs. Current Topics in Microbiology and Immunology, vol 244. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58537-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-58537-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63634-9
Online ISBN: 978-3-642-58537-1
eBook Packages: Springer Book Archive